The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma

References

• Bastos-Oreiro M, Muntañola A, Panizo C, et al. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group. Ann Hematol. 2020;99(4):799–808.
   PubMed Web of Science ®Google Scholar
• Mozas P, Nadeu F, Rivas-Delgado A, et al. Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience. Blood Cancer J. 2020;10(3):1–9.
   PubMed Web of Science ®Google Scholar
• Bachy E, Seymour JF, Feugier P, et al. Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study. J Clin Oncol. 2019;37(31):2815–2824.
   PubMed Web of Science ®Google Scholar
• Casulo C, Byrtek M, Dawson KL, et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study. J Clin Oncol. 2015;33(23):2516–2522.
   PubMed Web of Science ®Google Scholar
• Montoto S, Fitzgibbon J. Transformation of indolent B-cell lymphomas. J Clin Oncol. 2011;29(14):1827–1834.
   PubMed Web of Science ®Google Scholar
• Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–1265.
   PubMed Web of Science ®Google Scholar
• Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27(27):4555–4562.
   PubMed Web of Science ®Google Scholar
• Bachy E, Maurer MJ, Habermann TM, et al. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy. Blood. 2018;132(1):49–58.
   PubMed Web of Science ®Google Scholar
• Mozas P, Rivero A, López-Guillermo A. Past, present and future of prognostic scores in follicular lymphoma. Blood Rev. 2021;50:100865.
   PubMed Web of Science ®Google Scholar
• Mayne ST, Playdon MC, Rock CL. Diet, nutrition, and cancer: past, present and future. Nat Rev Clin Oncol. 2016;13(8):504–515.
   PubMed Web of Science ®Google Scholar
• Dalia S, Chavez J, Little B, et al. Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Ann Hematol. 2014;93(8):1305–1312.
   PubMed Web of Science ®Google Scholar
• Bairey O, Shacham-Abulafia A, Shpilberg O, et al. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor. Hematol Oncol. 2016;34(4):184–192.
   PubMed Web of Science ®Google Scholar
• de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol. 2005;23(26):6358–6363.
   PubMed Web of Science ®Google Scholar
• Siddiqui M, Ristow K, Markovic SN, et al. Absolute lymphocyte count predicts overall survival in follicular lymphomas. Br J Haematol. 2006;134(6):596–601.
   PubMed Web of Science ®Google Scholar
• Yang G, Mills M, Kim Y, et al. Enhancement of the follicular lymphoma international prognostic index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation. Blood Cancer J. 2020;9(12):104.
   PubMed Web of Science ®Google Scholar
• Buzby GP, Mullen JL, Matthews DC, et al. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1):160–167.
   PubMed Web of Science ®Google Scholar
• Sun K, Chen S, Xu J, et al. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2014;140(9):1537–1549.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao P, Song Y, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol. 2016;42(8):1176–1182.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Y, Zhang X, et al. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: review and meta-analysis. Clin Chim Acta. 2018;486:303–310.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wei Y, Huang F, et al. Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP. Int J Hematol. 2016;104(4):485–490.
   PubMed Web of Science ®Google Scholar
• Periša V, Zibar L, Knezović A, et al. Prognostic nutritional index as a predictor of prognosis in patients with diffuse large B cell lymphoma. Wien Klin Wochenschr. 2017;129(11–12):411–419.
   PubMed Web of Science ®Google Scholar
• Yu W, Guo Q, Wang Z, et al. Clinical significance of prognostic nutritional index for patients with diffuse large B-cell lymphoma. Nutr Cancer. 2019;71(4):569–574.
   PubMed Web of Science ®Google Scholar
• Hamada E, Shinji O, Nishiyama-Fujita Y, et al. The clinical significance of the prognostic nutritional index in very elderly patients over 80 years of age with diffuse large B-cell lymphoma. Ann Hematol. 2020;99(5):1153–1155.
   PubMed Web of Science ®Google Scholar
• Go S, Il Park S, Kang MH, et al. Clinical impact of prognostic nutritional index in diffuse large B cell lymphoma. Ann Hematol. 2019;98(2):401–411.
   PubMed Web of Science ®Google Scholar
• Chen KL, Liu YH, Li WY, et al. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type. Ann Hematol. 2015;94(8):1389–1400.
   PubMed Web of Science ®Google Scholar
• Lee SF, Ng TY, Wong FCS. The value of prognostic nutritional index in follicular lymphoma. Am J Clin Oncol. 2019;42(2):202–207.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Mozas P, Rivas-Delgado A, Rivero A, et al. High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. Leuk Res. 2020;94:106371.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3067.
   PubMed Web of Science ®Google Scholar
• Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 1997;15(3):1110–1117.
   PubMed Web of Science ®Google Scholar
• Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 2007;16:1141–1154.
   Google Scholar
• Diaz-Jauanen E, Strickland RG, Williams RC. Studies of human lymphocytes in the newborn and the aged. Am J Med. 1975;58(5):620–628.
   PubMed Web of Science ®Google Scholar
• Valiathan R, Ashman M, Asthana D. Effects of ageing on the immune system: infants to elderly. Scand J Immunol. 2016;83(4):255–266.
   PubMed Web of Science ®Google Scholar
• Salive ME, Cornoni-Huntley J, Phillips CL, et al. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol. 1992;45(3):213–221.
   PubMed Web of Science ®Google Scholar
• Gomi I, Fukushima H, Shiraki M, et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol. 2007;53(1):37–42.
   PubMed Web of Science ®Google Scholar
• Sarkozy C, Maurer MJ, Link BK, et al. Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts. J Clin Oncol. 2019;37(2):144–152.
   PubMed Web of Science ®Google Scholar
• Aviles A, Yanez J, Lopez T, et al. Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res. 1995;26:31–34.
   PubMedGoogle Scholar
• Brenner DA, Buck M, Feitelberg SP, et al. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia . J Clin Invest. 1990;85(1):248–255.
   PubMed Web of Science ®Google Scholar